Cutaneous, oral and genital lichenoid reactions associated with retifanlimab, a new PD-1 inhibitor.
Claire van DammeAnne DemolsVéronique Del MarmolPublished in: Journal of the European Academy of Dermatology and Venereology : JEADV (2022)
Keyphrases